Alex Nemiroff - Jan 10, 2025 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Signature
/s/ Alex Nemiroff
Stock symbol
PRAX
Transactions as of
Jan 10, 2025
Transactions value $
-$36,564
Form type
4
Date filed
1/14/2025, 06:50 PM
Previous filing
Jan 8, 2025
Next filing
Feb 14, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAX Common Stock Award $0 +11.3K +110.17% $0.00 21.5K Jan 10, 2025 Direct F1
transaction PRAX Common Stock Tax liability -$36.6K -579 -2.7% $63.15 20.9K Jan 12, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRAX Stock Option (Right to Buy) Award $0 +22.5K $0.00 22.5K Jan 10, 2025 Common Stock 22.5K $63.15 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Nemiroff was awarded 11,250 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 10, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
F2 Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units.
F3 The shares underlying this stock option vest over a four-year period, with 25% vesting on January 10, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.